Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Haferlach

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Leukemia|July 1, 1996
More individual markers are necessary for patients with acute myeloid leukemia (AML). Does cytomorphology or cytogenetics define the biological entity?T Haferlach
Leukemia Research|January 4, 2001
Quantitative reverse transcriptase-polymerase chain reaction in AML with t(8;21)(q22;q22)T Haferlach
Der Internist|January 15, 2003
[Modern techniques in leukemia diagnosis]T Haferlach, C Schoch
Leukemia|January 22, 1998
Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectivesT Haferlach, H Löffler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Dreams can come true: the first steps toward a peripheral blood screening test for the early detection of tumors have been takenC Haferlach, T Haferlach
Der Internist|February 12, 1998
[Liver involvement in hematologic diseases]T Haferlach, W Hiddemann
Deutsche Medizinische Wochenschrift (1946)|March 1, 2002
[WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)]T Haferlach, C Schoch
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|November 1, 1990
[An endodermal sinus tumor (yolk sac tumor) of the anterior mediastinum]G Sötje, D Schröder, T Haferlach
Leukemia & Lymphoma|January 1, 1995
AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspectsH Löffler, W Gassmann, T Haferlach
Deutsche Medizinische Wochenschrift (1946)|January 29, 2005
[Immunophenotyping in modern leukemia diagnosis]W Kern, H Diem, T Haferlach
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Leukemia|July 1, 1996
More individual markers are necessary for patients with acute myeloid leukemia (AML). Does cytomorphology or cytogenetics define the biological entity?T Haferlach
Leukemia Research|January 4, 2001
Quantitative reverse transcriptase-polymerase chain reaction in AML with t(8;21)(q22;q22)T Haferlach
Der Internist|January 15, 2003
[Modern techniques in leukemia diagnosis]T Haferlach, C Schoch
Leukemia|January 22, 1998
Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectivesT Haferlach, H Löffler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Dreams can come true: the first steps toward a peripheral blood screening test for the early detection of tumors have been takenC Haferlach, T Haferlach
Der Internist|February 12, 1998
[Liver involvement in hematologic diseases]T Haferlach, W Hiddemann
Deutsche Medizinische Wochenschrift (1946)|March 1, 2002
[WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)]T Haferlach, C Schoch
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|November 1, 1990
[An endodermal sinus tumor (yolk sac tumor) of the anterior mediastinum]G Sötje, D Schröder, T Haferlach
Leukemia & Lymphoma|January 1, 1995
AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspectsH Löffler, W Gassmann, T Haferlach
Deutsche Medizinische Wochenschrift (1946)|January 29, 2005
[Immunophenotyping in modern leukemia diagnosis]W Kern, H Diem, T Haferlach
Pageof 20